Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40959

EIF2AK3 Knockout CaSki Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Squamous cell carcinoma

The EIF2AK3 Knockout Ca Ski Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of human Ca Ski epithelial cells with targeted disruption of the EIF2AK3 gene, encoding the ER stress sensor kinase PERK. The Ca Ski line is derived from a cervical carcinoma and contains integrated HPV-16 sequences, offering a disease-relevant model for studying PERK signaling in cancer. This knockout tool enables investigation of the unfolded protein response, eIF2?? phosphorylation, and downstream effectors such as ATF4, CHOP, and GADD34. Ideal applications include ER stress assays with tunicamycin or thapsigargin, signaling pathway analysis, HPV-host interaction studies, and drug discovery targeting UPR components in cervical cancer.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    CaSki

    Sex of Donor

    Female

    Age

    40 years

    Derived From Site

    Metastatic; Small intestine

    Gene Name

    EIF2AK3

    Gene Identifier

    NCBI Gene ID 9451

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EIF2AK3 Knockout Ca Ski Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal population derived from the Ca Ski human cervical carcinoma cell line, with targeted disruption of the EIF2AK3 gene encoding PERK. This polyclonal format provides a heterogeneous mixture of knockout cells, avoiding clonal selection biases. The model is designed for investigating ER stress signaling and the unfolded protein response (UPR) in an epithelial cancer context.

Ca Ski is an adherent human epithelial cell line originating from a cervical epidermoid carcinoma, carrying integrated HPV-16 genomes and expressing viral oncoproteins E6 and E7. The cells are a well-established model for cervical cancer research, particularly for studies of HPV-mediated transformation, viral?Chost interactions, and therapeutic response.

EIF2AK3/PERK is an ER-resident kinase that senses ER stress through GRP78/BiP dissociation upon unfolded protein accumulation. Activated PERK phosphorylates eIF2??, attenuating global translation while selectively upregulating ATF4, which transcriptionally induces CHOP (DDIT3) and GADD34 (PPP1R15A). PERK signaling is triggered by oxidative stress, hypoxia, nutrient deprivation, and viral infection, and interfaces with apoptosis via TRAF2 and caspase-12. This pathway governs cell fate decisions between adaptation and programmed cell death under proteotoxic stress.

In the Ca Ski background, EIF2AK3 knockout allows dissection of PERK??s role in cervical carcinoma cells that naturally express HPV oncoproteins. The model is well-suited for examining how HPV-16 and PERK signaling co-regulate stress responses, chemoresistance, and apoptosis. It provides a platform to study synthetic lethality and identify vulnerabilities arising from loss of PERK function in an HPV-positive epithelial environment.

Research applications include quantitative analysis of UPR markers (phospho-eIF2??, ATF4, CHOP) by western blotting and RT-qPCR, and functional assays with ER stress inducers such as tunicamycin or thapsigargin. The cells can be used in ATF4-luciferase reporter systems, co-immunoprecipitation of PERK?CGRP78 complexes, immunofluorescence, and flow cytometry for apoptosis. They also support cell viability screens and studies on virus?Chost interactions. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)